Skip to main content
Erschienen in: Reactions Weekly 1/2011

01.05.2011 | Media release

“Omega Alpha Kidney Flush” is being recalled by its manufacturer in conjunction with Health Canada due to the omission of safety information

Erschienen in: Reactions Weekly | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

“Omega Alpha Kidney Flush” is being recalled by its manufacturer in conjunction with Health Canada due to the omission of safety information on the product's label. Omega Alpha Kidney Flush (UPC code 826913121805) is designed for occasional use only and poses health risks in vulnerable populations such as those with kidney disease, cardiovascular disorders and pregnant or breastfeeding women. Canadians, particularly pregnant women and those with kidney disorders, are advised to return the product to the place of purchase for a full refund. Patients with concerns are asked to consult their healthcare professional or contact Omega Pharmaceuticals Inc. All new product labelling will be updated accordingly. …
Literatur
1.
Zurück zum Zitat Health Canada.“Omega Alpha Kidney Flush“ Being Recalled from the Canadian Market: May Cause Serious Adverse Reactions in Pregnant Women and Kidney Disease Patients. Media Release: 4 May 2011. Available from: URL: http://www.healthcanada.gc.ca Health Canada.“Omega Alpha Kidney Flush“ Being Recalled from the Canadian Market: May Cause Serious Adverse Reactions in Pregnant Women and Kidney Disease Patients. Media Release: 4 May 2011. Available from: URL: http://​www.​healthcanada.​gc.​ca
Metadaten
Titel
“Omega Alpha Kidney Flush” is being recalled by its manufacturer in conjunction with Health Canada due to the omission of safety information
Publikationsdatum
01.05.2011
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2011
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201113510-00007

Weitere Artikel der Ausgabe 1/2011

Reactions Weekly 1/2011 Zur Ausgabe

Case report

Minocycline

Case report

Risperidone

Case report

Baclofen

Case report

Rosiglitazone